Medications starting with

Poland
  • EPLERENONE MEDICAL VALLEY

    The medicine is used to treat heart failure to prevent the disease from worsening and to reduce the number of hospitalizations. It is used in people who have had a heart attack (in combination with other medicines) or when mild symptoms persist despite previous treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eplerenone 50 mg

    ATC code: C03DA04

    Manufacturer: Iasis Pharmaceuticals Hellas S.A.-Koropi

  • The medicine is used in the treatment of heart failure to prevent its worsening and to reduce the number of hospitalizations, especially in people following a recent heart attack or in patients with persistent, mild symptoms despite current treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eplerenone 25 mg

    ATC code: C03DA04

    Manufacturer: Medis International a.s.

  • The medicine is used in the treatment of heart failure to prevent its worsening and to reduce the number of hospitalizations. It is intended for individuals who have recently suffered a heart attack or for patients with persistent, mild symptoms of heart failure.

    Dosage form: tablets, film-coated

    Active substance Dosage
    eplerenone 50 mg

    ATC code: C03DA04

    Manufacturer: Medis International a.s.

  • The medicine is used in adult patients with type 2 diabetes to balance blood sugar levels. It helps increase the amount of insulin released after a meal and reduces the amount of sugar produced by the body.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sitagliptin 50 mg
    metformin hydrochloride 850 mg

    ATC code: A10BD07

    Manufacturer: Lek d.d., PE PROIZVODNJA LENDAVA Lek S.A.

  • The medicine is used in adult patients with type 2 diabetes to balance blood sugar levels. It helps increase the amount of insulin released after a meal and reduces the amount of sugar produced by the body.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sitagliptin 50 mg
    metformin hydrochloride 1000 mg

    ATC code: A10BD07

    Manufacturer: Lek d.d., PE PROIZVODNJA LENDAVA Lek S.A.

  • The medicine is used to reduce the body's immune response. In patients following organ, bone marrow, or stem cell transplants, it prevents transplant rejection. It is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe skin diseases (atopic dermatitis, psoriasis), rheumatoid arthritis, and nephrotic syndrome.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    ciclosporin 25 mg

    ATC code: L04AD01

    Manufacturer: Teva Czech Industries s.r.o. Teva Operations Polska Sp. z o.o.

  • The medicine is used to reduce the body's immune response. It helps prevent the rejection of transplanted organs, bone marrow, or stem cells, and is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe skin diseases (atopic dermatitis, psoriasis), rheumatoid arthritis, or nephrotic syndrome.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    ciclosporin 50 mg

    ATC code: L04AD01

    Manufacturer: Teva Czech Industries s.r.o. Teva Operations Polska Sp. z o.o.

  • The medicine is used to reduce the body's immune response. In patients following organ, bone marrow, or stem cell transplants, it prevents transplant rejection. It is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe skin diseases (atopic dermatitis, psoriasis), rheumatoid arthritis, and nephrotic syndrome.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    ciclosporin 100 mg

    ATC code: L04AD01

    Manufacturer: Teva Czech Industries s.r.o. Teva Operations Polska Sp. z o.o.

  • The medicine is used in patients after an organ, bone marrow, or stem cell transplant to prevent transplant rejection. It is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe cases of atopic dermatitis, psoriasis, rheumatoid arthritis, and nephrotic syndrome.

    Dosage form: solution, oral

    Active substance Dosage
    ciclosporin 100 mg/ml

    ATC code: L04AD01

    Manufacturer: Teva Pharma - Produtos Farmacêuticos, Ltd.

  • The medicine is used to treat early symptoms of recurrent herpes labialis in adults and children over 12 years of age.

    Dosage form: cream

    Active substance Dosage
    doconazole 100 mg

    ATC code: D06BB11

    Manufacturer: Laboratori Fundació Dau

  • The medicinal product is used in the treatment of diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It is also used preventatively during seasonal exacerbations of chronic bronchitis.

    Dosage form: powder for preparation of oral suspension

    Active substance Dosage
    erdosteine 35 mg/ml

    ATC code: R05CB15

    Manufacturer: Fulton Medicinali S.p.A. Zeta Farmaceutici S.p.A.

  • The medicine is used to treat diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It is also used to prevent seasonal exacerbations of chronic bronchitis.

    Dosage form: capsules, hard

    Active substance Dosage
    erdosteine 300 mg

    ATC code: R05CB15

    Manufacturer: Angelini Pharma Czech Republic s.r.o.

  • It is used in the treatment of diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It may also be used preventatively during seasonal exacerbations of chronic bronchitis.

    Dosage form: capsules, hard

    Active substance Dosage
    erdosteine 300 mg

    ATC code: R05CB15

    Manufacturer: Angelini Pharma Czech Republic s.r.o.

  • The medicinal product is used in the treatment of diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates its expectoration. It is also used to prevent seasonal exacerbations of chronic bronchitis.

    Dosage form: capsules, hard

    Active substance Dosage
    erdosteine 300 mg

    ATC code: R05CB15

    Manufacturer: Angelini Pharma Czech Republic s.r.o.

  • The medicine is used to thin and facilitate the expectoration of mucus from the respiratory tract. It is used as support in the treatment of inflammation of the nose, sinuses, larynx, trachea, bronchi, and lungs.

    Dosage form: powder for preparation of oral suspension

    Active substance Dosage
    erdosteine 225 mg

    ATC code: R05CB15

    Manufacturer: Fine Food & Pharmaceuticals NTM S.P.A.

  • The medicine is used to facilitate expectoration and reduce the viscosity of secretions in acute and chronic diseases of the respiratory tract, bronchi, and lungs. It also helps in preventing seasonal exacerbations of chronic bronchitis.

    Dosage form: powder for preparation of oral suspension

    Active substance Dosage
    erdosteine 35 mg/ml

    ATC code: R05CB15

    Manufacturer: Mako Pharma Sp. z o.o.

  • The medicine is used to treat diseases of the upper respiratory tract, bronchi, and lungs associated with mucus secretion problems. It helps to reduce the viscosity of the secretion and facilitates expectoration. It is also used preventatively during seasonal exacerbations of chronic bronchitis.

    Dosage form: tablets

    Active substance Dosage
    erdosteine 300 mg

    ATC code: R05CB15

    Manufacturer: Mako Pharma Sp. z o.o.

  • The medicine helps to thin and facilitate the expectoration of mucous secretion from the respiratory tract. It is used as support in the treatment of acute and chronic inflammation of the nose, sinuses, larynx, trachea, bronchi, and lungs.

    Dosage form: tablets

    Active substance Dosage
    erdosteine 225 mg

    ATC code: R05CB15

    Manufacturer: Mako Pharma Sp. z o.o.

  • It is used to treat fungal skin infections (e.g., groin, feet, or hairy scalp) and nail fungus caused by dermatophytes. However, it is not effective in treating pityriasis versicolor.

    Dosage form: tablets

    Active substance Dosage
    terbinafine hydrochloride 281.3 mg

    ATC code: D01BA02

    Manufacturer: Polfarmex S.A.

  • The medicine is used to prevent and treat vascular headaches, including migraine headaches and cluster headaches.

    Dosage form: tablets, coated

    Active substance Dosage
    ergotamine tartrate 1 mg

    ATC code: N02CA

    Manufacturer: Pharmaceutical Workers' Cooperative FILOFARM

  • The medicine is intended for adults with advanced breast cancer or metastatic breast cancer (after other therapies have ceased to be effective). It is also used in the treatment of advanced liposarcoma or metastatic liposarcoma, when other treatment methods have proven ineffective.

    Dosage form: solution for injection

    Active substance Dosage
    eribulin 0.44 mg/ml

    ATC code: L01XX41

    Manufacturer: EVER Pharma Jena GmbH Oncomed manufacturing a.s.

  • The medicine is used in adults to prevent the formation of blood clots in the heart (in patients with atrial fibrillation) and for the treatment and prevention of recurrence of clots in the veins of the lower limbs and pulmonary vessels. In children and adolescents, it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

    Dosage form: capsules, hard

    Active substance Dosage
    apixaban 5 mg

    ATC code: B01AF02

    Manufacturer: Adamed Pharma S.A.

  • Erimpox is used in adults to prevent the formation of blood clots after hip or knee surgery and in people with an irregular heartbeat (atrial fibrillation) to prevent stroke. It is also used to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence. In children and adolescents, it is used to treat and prevent clots in the veins or pulmonary vessels.

    Dosage form: capsules, hard

    Active substance Dosage
    apixaban 2.5 mg

    ATC code: B01AF02

    Manufacturer: Adamed Pharma S.A.

  • It is intended for adult men with erectile dysfunction. It helps improve the ability to achieve an erection sufficient for sexual intercourse.

    Dosage form: tablets, film-coated

    Active substance Dosage
    tadalafil 2.5 mg

    ATC code: G04BE08

    Manufacturer: Pharmacare Premium Ltd. Pharmaceutical Plants POLPHARMA S.A. Pharmaceutical Plants POLPHARMA S.A. Production Branch in Nowa Dęba

  • The medicine is used in adult men to treat erectile dysfunction and to relieve symptoms associated with benign prostatic hyperplasia (such as difficulty urinating or frequent urination).

    Dosage form: tablets, film-coated

    Active substance Dosage
    tadalafil 5 mg

    ATC code: G04BE08

    Manufacturer: Pharmacare Premium Ltd. Pharmaceutical Plants POLPHARMA S.A. Pharmaceutical Plants POLPHARMA S.A. Production Branch in Nowa Dęba

  • The medicine is intended for adult men with erectile dysfunction. It helps to achieve and maintain an erection necessary for sexual intercourse, but it only works when sexual stimulation is present.

    Dosage form: tablets, film-coated

    Active substance Dosage
    tadalafil 10 mg

    ATC code: G04BE08

    Manufacturer: Pharmacare Premium Ltd. Pharmaceutical Plants POLPHARMA S.A. Pharmaceutical Plants POLPHARMA S.A. Production Branch in Nowa Dęba

  • The medicine is intended for adult men with erectile dysfunction, a condition in which a man is unable to achieve or maintain an erection sufficient for sexual intercourse.

    Dosage form: tablets, film-coated

    Active substance Dosage
    tadalafil 20 mg

    ATC code: G04BE08

    Manufacturer: Pharmacare Premium Ltd. Pharmaceutical Plants POLPHARMA S.A. Pharmaceutical Plants POLPHARMA S.A. Production Branch in Nowa Dęba

  • The medicinal product is intended for adult patients with advanced non-small cell lung cancer (as first-line treatment or when the disease has not responded to chemotherapy, provided specific EGFR mutations are present) and for patients with metastatic pancreatic cancer (used in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib hydrochloride 27.32 mg

    ATC code: L01EB02

    Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o.

  • The medicinal product is intended for adult patients with advanced non-small cell lung cancer (as first-line treatment or when the disease has not responded to chemotherapy, provided that specific EGFR mutations are present) and for patients with metastatic pancreatic cancer (used in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib hydrochloride 109.27 mg

    ATC code: L01EB02

    Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o.

  • The medicinal product is used in adult patients with advanced non-small cell lung cancer (as first-line treatment or when the disease has not responded to chemotherapy, provided that specific EGFR mutations are present) and in patients with metastatic pancreatic cancer (in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib hydrochloride 163.9 mg

    ATC code: L01EB02

    Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o.

  • The medicine is intended for adult patients with advanced non-small cell lung cancer (provided specific EGFR mutations are present) or in the case of metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 25 mg

    ATC code: L01XE03

    Manufacturer: S.C. Terapia S.A., Sun Pharmaceutical Industries Europe B.V.

  • The medicinal product is used in adult patients with advanced non-small cell lung cancer (provided that specific EGFR mutations are present) and in patients with metastatic pancreatic cancer (in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 100 mg

    ATC code: L01XE03

    Manufacturer: S.C. Terapia S.A., Sun Pharmaceutical Industries Europe B.V.

  • The medicine is used in adult patients for the treatment of advanced non-small cell lung cancer (depending on the cancer cell mutations) and for the treatment of metastatic pancreatic cancer (in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 150 mg

    ATC code: L01XE03

    Manufacturer: S.C. Terapia S.A., Sun Pharmaceutical Industries Europe B.V.

  • The medicine is used in adult patients for the treatment of advanced non-small cell lung cancer (when the cancer cells have specific EGFR mutations) and in the treatment of metastatic pancreatic cancer (in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 25 mg

    ATC code: L01EB02

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used in adult patients for the treatment of advanced non-small cell lung cancer (when the cancer cells have specific EGFR mutations) or in cases where previous chemotherapy has not been effective. It may also be used in the treatment of metastatic pancreatic cancer in combination with gemcitabine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 100 mg

    ATC code: L01EB02

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is intended for adult patients with advanced non-small cell lung cancer (provided specific EGFR mutations are present) and for patients with metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 150 mg

    ATC code: L01EB02

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is intended for adult patients with advanced non-small cell lung cancer (as first-line treatment or when the disease has not responded to chemotherapy) and in the case of metastatic pancreatic cancer (used in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 25 mg

    ATC code: L01EB02

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is intended for adult patients with advanced non-small cell lung cancer (provided that specific EGFR mutations are present) or in the case of metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 100 mg

    ATC code: L01EB02

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicinal product is used in adult patients with advanced non-small cell lung cancer and in patients with metastatic pancreatic cancer (in which case it is used in combination with gemcitabine).

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 150 mg

    ATC code: L01EB02

    Manufacturer: Synthon B.V., Synthon Hispania S.L.

  • The medicine is used to treat abdominal infections, lung infections (pneumonia), gynecological infections, and skin infections of the foot in people with diabetes. It may also be used to prevent infections at the surgical site following procedures on the colon or rectum.

    Dosage form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    ertapenem 1 g

    ATC code: J01DH03

    Manufacturer: ACS Dobfar S.p.A.

  • The medicine is used to treat infections of the abdominal cavity, lungs (pneumonia), gynecological infections, and skin infections of the foot in people with diabetes. It may also be used to prevent infections of the surgical site following procedures on the colon or rectum in adults.

    Dosage form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    ertapenem sodium 1046 mg

    ATC code: J01DH03

    Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmaceutica, S.A.

  • The medicinal product is an antibiotic used to treat infections of the abdomen, lungs (pneumonia), gynecological infections, and skin infections of the foot in people with diabetes. It may also be used to prevent infections of the surgical site following procedures on the colon or rectum.

    Dosage form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    ertapenem sodium No input provided

    ATC code: J01DH03

    Manufacturer: ACS Dobfar S.p.A.

  • The medicine is intended for the treatment of erectile dysfunction (impotence) in adult men. It helps to achieve or maintain an erection, but it only works when sexual arousal has occurred.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sildenafil citrate 35.125 mg

    ATC code: G04BE03

    Manufacturer: Adamed Pharma S.A.

  • The medicine is intended for adult men to treat erectile dysfunction (impotence), which is the difficulty in achieving or maintaining an erection sufficient for sexual intercourse.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sildenafil citrate 70.25 mg

    ATC code: G04BE03

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used to treat blood cancer, mainly in children with acute lymphoblastic leukemia who have had an allergic reaction to other similar medicines. It is used in conjunction with other treatment methods.

    Dosage form: powder for preparation of solution for injection / infusion

    Active substance Dosage
    crisantaspase 10000 IU

    ATC code: L01XX02

    Manufacturer: Almac Pharma Services Limited

  • This medicine is used to treat severe infections caused by susceptible microorganisms when it is necessary to rapidly achieve high drug concentrations in the blood or when oral administration is not possible. It is used, among others, in respiratory tract, ear, skin, soft tissue, and gastrointestinal tract infections, as well as in cases of sepsis or endocarditis.

    Dosage form: solution for infusion, powder for preparation of

    Active substance Dosage
    erythromycin 300 mg

    ATC code: J01FA01

    Manufacturer: Fisiopharma S.r.L. Tarchomin Pharmaceutical Works 'Polfa' S.A.

  • This medicine is used to treat infections caused by bacteria sensitive to erythromycin. It may be used, among others, for upper and lower respiratory tract infections (e.g., pharyngitis, pneumonia, sinusitis), ear, skin, and soft tissue infections, gastrointestinal tract infections, as well as for gonorrhea, syphilis, or diphtheria.

    Dosage form: tablets, film-coated

    Active substance Dosage
    erythromycin No input provided

    ATC code: J01FA01

    Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

  • The medicine is used as an emergency contraception method in urgent situations, such as unprotected sexual intercourse or the failure of a current contraceptive method (e.g., a broken condom).

    Dosage form: tablets

    Active substance Dosage
    levonorgestrel 1500 mcg

    ATC code: G03AD01

    Manufacturer: Gedeon Richter Plc.

  • The medicine is a method of emergency contraception used in urgent situations, e.g., when no protection was used during intercourse or when a contraceptive method has failed (e.g., a condom broke).

    Dosage form: tablets

    Active substance Dosage
    levonorgestrel 1500 mcg

    ATC code: G03AD01

    Manufacturer: Gedeon Richter Plc.

  • The medicinal product is a method of emergency contraception used in urgent situations, e.g., when unprotected sexual intercourse has occurred or when a contraceptive method has failed (e.g., a condom broke).

    Dosage form: tablets

    Active substance Dosage
    levonorgestrel 1500 mcg

    ATC code: G03AD01

    Manufacturer: Gedeon Richter Plc.